COVID-19 Action Fund
Leading in a pandemic
We are taking swift, decisive action to better understand — and halt — COVID-19 and future pandemic threats.
The COVID-19 Action Fund enables responsive, meaningful action and collaboration during this unprecedented time.
100% of your donation today will support innovation and research collaborations that accelerate solutions to COVID-19.
In today’s crisis, we are addressing pressing questions about COVID-19:
Can medical imaging and AI predict how sick someone will become following infection?
How is the virus mutating as it is transmitted through the population?
What does COVID-19 do to the brain?
CIFAR is mobilizing our global community of scientists and policy experts to advance innovative solutions and actions.
When the pandemic struck, we convened over 70 global researchers to identify gaps in knowledge and areas of collaboration. As a trusted resource for policy makers, we brought urgent insights to influential Canadian and international policy makers in the first of a series of policy briefings.
We also launched AI and COVID-19 Catalyst Grants to spark out-of-the-box ideas and projects.
With an extensive network of research, government, policy, and industry contacts across Canada and the world, CIFAR is uniquely placed to catalyze important COVID-19 research.
Our President and CEO, Dr. Alan Bernstein, built a career studying retroviruses before leading key science institutions at crucial moments of growth and change. He was the president of the Canadian Institutes of Health Research during the SARS crisis in 2003 and was executive director of the Global HIV Vaccine Enterprise. He is now a member of Canada's Vaccine Task Force. In this crisis, he has quickly emerged as a trusted global leader, identifying knowledge gaps, making connections, and catalyzing new directions of research.
You too can make a difference. Please join us in pursuing coordinated, collaborative, interdisciplinary research.
CIFAR is a registered charitable organization supported by the governments of Canada, Alberta, Ontario, and Quebec as well as foundations, individuals, corporations, and international partner organizations.